Advances in the Treatment of Generalized Myasthenia Gravis: Which of Your Patients May Benefit from Targeted Immunotherapies?
Recorded Courses
hosted byMed Learning Group
hosted byMed Learning Group
attend it anywhere online
category
Medicine, Nursing, Pharmacy
Neurology, Immunotherapies
price
Free
speakers
Advances in the Treatment of Generalized Myasthenia Gravis: Which of Your Patients May Benefit from Targeted Immunotherapies? is organized by Med Learning Group.
Program Overview:
This enduring activity focuses on the treatment and management of patients with generalized myasthenia gravis (gMG).
Learning objectives:
On completing this program, attendees should be able to:
• Select appropriate treatments for patients with generalized MG based on their specific clinical characteristics
• Assess results from clinical trials evaluating emerging targeted therapies for the treatment of patients with generalized MG
• Predict the potential benefits of emerging targeted therapies for the treatment of generalized MG